Obesity Found to Increase Irregular Heartbeat Risk – Newsmax

Related posts:

1. 36-percent increase in pediatric patients treated with proton therapy, new survey shows Results from an American survey indicate a steady increase in the number of pediatric patients who are being treated with proton radiation therapy for cancerous and non-cancerous tumors. Based on a survey of all proton therapy centers in the United States, the number of pediatric patients treated with proton therapy grew to 722 in 2013, a 36-percent increase from the 465 patients treated in 2010....
2. Oxytocin May Effectively Treat Autism Spectrum Disorder A research team at Yale School of Medicine, which includes postdoctoral fellow Ilanit Gordon and Kevin Pelphrey, the Harris Associate Professor of Child Psychiatry and Psychology, have discovered that oxytocin increases function in specific regions of the brain associated with processing social information in children and adolescents with autism spectrum disorders (ASD)."Our findings provide the first, critical steps toward devising more effective treatments for the core social deficits in autism, which may involve a combination of clinical interventions with an administration of oxytocin," said Gordon. "Such a treatment approach will fundamentally improve our understanding of autism and its treatment."Autism spectrum...
3. Robb Wolf – Carnivore Identity Crisis, IF and Blood Glucose, Severe Constipation Please Subscribe and Review: Apple Podcasts | RSS Submit your questions for the podcast here......
4. Ossur to announce clinical trials for implanted myoelectric sensors for brain-controlled prosthetics Ossur, an Icelandic based prosthetics development company is set to announce the beginning of clinical trials for its Proprio foot, a new kind of brain controlled prosthetic ankle and foot. Instead of trying to connect the device to nerves, the robotic limb uses sensors to detect nerve signals in muscles near the point where the limb was removed. The limb then analyses those signals and converts them to movement in real time, which is reportedly very close to that of natural limbs....
5. FDA Approves Device To Treat Obesity Recently, the U.S. Food and Drug Administration approved the very first weight loss device that controls satiety. The Maestro Rechargeable System targets the neural pathway between the brain and the stomach that controls feelings of hunger and fullness. However, this device will only be available to adults aged 18 years of age and older with a body mass index of 35-45 combined with at least one other obesity-related condition (i.e. type 2 diabetes) that have had no success with weight loss programs.How does it work?“The Maestro Rechargeable System consists of a rechargeable electrical pulse generator, wire leads and electrodes implanted...